Clinical signs and hematologic, cytokine, and plasma nitric oxide alterations in response to Strongylus vulgaris infection in helminth-naïve ponies

Canadian Journal of Veterinary Research

Volumn 68, Issue 3, 2004, Pages 193-200

  Hubert, Jeremy D ^a   Seahorn, Thomas L ^a   Klei, Thomas R ^b   Hosgood, Giselle ^a   Horohov, David W ^b   Moore, Rustin M ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRINOGEN; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; PLASMA PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL PARASITOSIS; ANOREXIA; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; ERYTHROPENIA; FEVER; FIBRINOGEN BLOOD LEVEL; HELMINTHIASIS; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HORSE; LARVAL STAGE; LEUKOCYTOSIS; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STRONGYLOIDEA; STRONGYLOIDIASIS;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; ERYTHROCYTE COUNT; FEMALE; HORSES; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; NITRIC OXIDE; STRONGYLE INFECTIONS, EQUINE; STRONGYLUS;

ANIMALIA; EQUUS CABALLUS; STRONGYLOIDEA; STRONGYLUS; STRONGYLUS VULGARIS; VERMES;

EID: 4444231698     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Drudge JH, Lyons ET, Szanto J. Pathogenesis of migrating stages of helminths, with special reference to Strongylus vulgaris. In: Soulsby EJL, ed. Biology of Parasites: Emphasis on diagnosis, chemotherapy, and prophylaxis. New York: Academic Press, 1966:199-214.
2. Drudge JH. Clinical aspects of Strongylus vulgaris infection in the horse: Emphasis on diagnosis, chemotherapy, and prophylaxis. Veterinary Clinics of North America: Large Animal Practice 1979;1:251-265.
3. Slocombe JOD. Pathogenesis of helminths in equines. Vet Parasitol 1985;18:139-153.
4. Duncan JL, Pirie HM. The pathogenesis of single experimental infections with Strongylus vulgaris in foals. Res Vet Sci 1975;18: 82-93.
5. Klei TR, Turk MA, McClure JR, Holmes RA, Dennis VA, Chapman MR. Effects of repeated Strongylus vulgaris inoculations and concurrent ivermectin treatments on mesenteric arterial lesions in pony foals. Am J Vet Res 1990;51:654-660.
6. Moore RM, Muir WW, Cawrse M, Bertone AL, Beard WL. Systemic and colonic venous plasma eicosanoid and endotoxin concentrations, and colonic venous serum tumor necrosis factor and interleukin-6 activities in horses during low-flow ischemia and reperfusion of the large colon. Am J Vet Res 1995;56: 656-663.
7. Morris DD. Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991;5:167-181.
8. Georgi JR. The Kikuchi-Enigk model of Strongylus vulgaris migrations in the horse. Cornell Vet 1973;63:220-222.
9. Miller MJS, Clark DA. Nitric oxide synthase inhibition can initiate or prevent inflammation: role of enzyme source. Agents Action 1994;41:231-232.
10. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-142.
12. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271: 1424-1437.
13. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
14. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288: 481-487.
15. Oswald IP, Wynn TA, Sher A, James SL. NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994;108: 11-18.
16. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995;59:533-547.
17. De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 1995;21:162-165.
18. Liew FY, Wei XQ, Proudfoot L. Cytokines and nitric oxide as effector molecules against parasitic infections. Philos Trans R Soc Lond B Biol Sci 1997;352:1311-1315.
19. Scharton-Kersten TM, Yap G, Magram J, Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 1997;185:1261-1273.
20. Monahan CM, Chapman MR, Taylor HW, French DD, Klei TR. Foals raised on pasture with or without daily pyrantel tartrate feed additive: comparison of parasite burdens and host responses following experimental challenge with large and small strongyle larvae. Vet Parasitol 1997;73: 277-289.
21. McClure JR, Chapman MR, Klei TR. Production and characterization of monospecific adult worm infections of Strongylus vulgaris and Stronglus edentatus in ponies. Vet Parasitol 1994;51: 249-254.
22. Klei TR, Torbert BJ, Chapman MR, Ochoa R. Irradiated larval vaccination of ponies against Strongylus vulgaris. J Parasitol 1982;68:561-569.
23. Bueno AC, Seahorn TL, Cornick-Seahorn J, Horohov DW, Moore RM. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am J Vet Res 1999;60:969-976.
24. Mirza MH, Oliver JL, Seahorn TL, Hosgood G, Moore RM. Detection and comparison of nitric oxide in clinically normal horses and those with naturally acquired small intestinal strangulation obstruction. Can J Vet Res 1999;63:230-240.
25. MacKay RJ, Merritt AM, Zertuche JM, Whittington M, Skelley LA. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533-538.
26. MacKay RJ, Lester GD. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. Am J Vet Res 1992;53:1285-1289.
27. Durando MM, MacKay RJ, Linda S, Skelley LA. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 1994;55:921-927.
28. Nakai S, Mizuno K, Kaneta M, Hirai Y. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 1988;154: 1189-1196.
29. Pluznik DH, Frappier N, Nordan RP. Interleukin 6 (interferon beta 2) and interferon alpha/beta present in postendotoxin serum induce differentiation of murine M1 myeloid leukemia cells. Exp Hematol 1989;17:1063-1066.
30. Amborski GF, Bello TR, Torbert BJ. Host response to experimentally induced infections of Strongylus vulgaris in parasite-free and naturally infected ponies. Am J Vet Res 1974;35:1181-1188.
31. Patton S, Drudge JH. Clinical response of pony foals experimentally infected with Strongylus vulgaris. Am J Vet Res 1977;38: 2059-2066.
32. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med 1988;5:409-419.
33. van der Poll T, Lowry SF. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? [editorial]. Shock 1995;3:1-12.
34. Swiderski CE, Klei TR, Folsom RW, et al. Vaccination against Strongylus vulgaris in ponies: comparison of the humoral and cytokine responses of vaccinates and nonvaccinates. Adv Vet Med 1999;41:389-404.
35. Finkelman FD, Pearce EJ, Urban JF Jr, Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991;12:62-66.
36. Sher A, Coffman RL, Hieny S, Scott P, Cheever AW. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87:61-65.
37. Monahan CM, Taylor HW, Chapman MR, Klei TR. Experimental immunization of ponies with Strongylus vulgaris radiation-attenuated larvae or crude soluble somatic extracts from larval or adult stages. J Parasitol 1994;80:911-923.
38. Cogswell AM, Johnson PJ, Adams HR. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries. Am J Vet Res 1995;56:1637-1641.
39. Simmons EJ, Bertone AL, Hardy J, Weisbrode SE. Nitric oxide synthase activity in healthy and interleukin-1 beta-exposed equine synovial membrane. Am J Vet Res 1999;60:714-716.
40. Costa LR, Seahorn TL, Moore RM, Oliver JL, Hosgood GL. Plasma and bronchoalveolar fluid concentrations of nitric oxide and localization of nitric oxide synthesis in the lungs of horses with summer pasture-associated obstructive pulmonary disease. Am J Vet Res 2001;62:1381-1386.
41. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993;7:349-360.
42. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol 1982;6: 148-152.
43. Lancaster J. Role of nitric oxide in septic (endotoxemic) shock. 12th Am Coll Vet Intern Med Forum 1994:750-751.
44. Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-2988.
45. del Pozo V, de Arruda-Chaves E, de Andres B, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859-864.
46. Oliveira SH, Fonseca SG, Romao PR, Ferreira SH, Cunha FQ. Nitric oxide mediates the microbicidal activity of eosinophils. Mem Inst Oswaldo Cruz 1997;92:233-235.